Target ID Services

Shantani supports early-stage drug discovery programs by offering an array of chemical proteomics technologies as services for small molecule target identification and validation. We utilize our expertise and deep understanding of proteomics in identifying the protein targets and elucidating the action mechanism of phenotypically screened compounds.  

A comparison of these and related small molecule target identification technologies is available below. Using our deep understanding of chemical proteomics, we will help you identify the most suitable method(s) for your drug discovery project. 

We enable Faster and Cost-Effective Drug Discovery & Development

By identifying fewer – yet rightful – targets and avoiding the validation of false positives, we help you save time and money during the drug discovery process. We have successfully identified several cytoplasmic, membrane (ie. GPCRs) and nuclear targets for our global clients